These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29527628)

  • 61. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
    Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
    J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness and safety of low-level laser therapy in diabetic peripheral neuropathy: a protocol for a systematic review and meta-analysis.
    Lin L; Li J; Lin J; Tang S; Li Y
    Syst Rev; 2021 Apr; 10(1):96. PubMed ID: 33810813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral gabapentin treatment accentuates nerve and peripheral inflammatory responses following experimental nerve constriction in Wistar rats.
    Câmara CC; Ramos HF; da Silva AP; Araújo CV; Gomes AS; Vale ML; Barbosa AL; Ribeiro RA; Brito GA; Costa CM; Oriá RB
    Neurosci Lett; 2013 Nov; 556():93-8. PubMed ID: 24140003
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies.
    Hahn K; Arendt G; Braun JS; von Giesen HJ; Husstedt IW; Maschke M; Straube ME; Schielke E;
    J Neurol; 2004 Oct; 251(10):1260-6. PubMed ID: 15503108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine.
    Arai YC; Matsubara T; Shimo K; Suetomi K; Nishihara M; Ushida T; Kobayashi K; Suzuki C; Kinoshita A; Kondo M; Matsubara S; Hayashi R; Tohyama Y; Nishida K; Arakawa M
    J Anesth; 2010 Jun; 24(3):407-10. PubMed ID: 20217150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy.
    Ko SH; Kwon HS; Yu JM; Baik SH; Park IB; Lee JH; Ko KS; Noh JH; Kim DS; Kim CH; Mok JO; Park TS; Son HS; Cha BY
    Diabet Med; 2010 Sep; 27(9):1033-40. PubMed ID: 20722677
    [TBL] [Abstract][Full Text] [Related]  

  • 68. S100B as a glial cell marker in diabetic peripheral neuropathy.
    Celikbilek A; Akyol L; Sabah S; Tanik N; Adam M; Celikbilek M; Korkmaz M; Yilmaz N
    Neurosci Lett; 2014 Jan; 558():53-7. PubMed ID: 24211224
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin-induced neuropathic pain model.
    Ahmad N; Subhan F; Islam NU; Shahid M; Rahman FU; Sewell RDE
    Eur J Pharmacol; 2017 Nov; 814():302-312. PubMed ID: 28865678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Painful diabetic neuropathy.
    Peltier A; Goutman SA; Callaghan BC
    BMJ; 2014 May; 348():g1799. PubMed ID: 24803311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low-level laser therapy alleviates mechanical and cold allodynia induced by oxaliplatin administration in rats.
    Hsieh YL; Fan YC; Yang CC
    Support Care Cancer; 2016 Jan; 24(1):233-242. PubMed ID: 26006084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil.
    Hayashida K; Parker R; Eisenach JC
    Anesthesiology; 2007 Jun; 106(6):1213-9. PubMed ID: 17525597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy.
    Erbaş O; Oltulu F; Yılmaz M; Yavaşoğlu A; Taşkıran D
    Diabetes Res Clin Pract; 2016 Apr; 114():106-16. PubMed ID: 26795972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evidence-based management of diabetic polyneuropathy. "Burning feet" alarm signal].
    Wepner U
    MMW Fortschr Med; 2004 Jul; 146(27-28):6, 8. PubMed ID: 15526650
    [No Abstract]   [Full Text] [Related]  

  • 75. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
    Pan Y; Davis PB; Kaebler DC; Blankfield RP; Xu R
    Cardiovasc Diabetol; 2022 Sep; 21(1):170. PubMed ID: 36050764
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased amino acids in the brain might contribute to the progression of diabetic neuropathic pain.
    Zhang Q; Li Q; Liu S; Zheng H; Ji L; Yi N; Zhu X; Sun W; Liu X; Zhang S; Li Y; Xiong Q; Lu B
    Diabetes Res Clin Pract; 2021 Jun; 176():108790. PubMed ID: 33812900
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beneficial effects of (-)-epigallocatechin-3-O-gallate on diabetic peripheral neuropathy in the rat model.
    Abo-Salem OM; Ali TM; Harisa GI; Mehanna OM; Younos IH; Almalki WH
    J Biochem Mol Toxicol; 2020 Aug; 34(8):e22508. PubMed ID: 32275810
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
    Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
    J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy.
    Al-Rejaie SS; Aleisa AM; Abuohashish HM; Parmar MY; Ola MS; Al-Hosaini AA; Ahmed MM
    Neurol Res; 2015 Oct; 37(10):924-33. PubMed ID: 26187552
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Frequency-dependent effects of sequenced pulsed magnetic field on experimental diabetic neuropathy.
    Mert T; Gisi G; Celik A; Baran F; Uremis MM; Gunay I
    Int J Radiat Biol; 2015; 91(10):833-42. PubMed ID: 26136088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.